Evidence map›Paper›PMID 37889003›Full record

ArticleInfection and immunity2023

Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against

Qiong Liu, Biaoxian Li, Jiahui Lu, Yejia Zhang, Yinpan Shang, Yi Li, Tian Gong, Chengsheng Zhang

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Frontiers in immunology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Qiong Liu *Center for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University , Nanchang, China.ORCID 0000-0002-8950-6133
Biaoxian Li *Center for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University , Nanchang, China.
Jiahui LuCenter for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University , Nanchang, China.
Yejia ZhangThe Department of Medical Microbiology, School of Medicine, Nanchang University , Nanchang, China.
Yinpan ShangThe Department of Medical Microbiology, School of Medicine, Nanchang University , Nanchang, China.
Yi LiThe Department of Medical Microbiology, School of Medicine, Nanchang University , Nanchang, China.
Tian GongCenter for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University , Nanchang, China.
Chengsheng ZhangCenter for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University , Nanchang, China.
Nanchang University · CN

Funding

Key Research and Development Projects of Jiangxi Natural Science Foundation 20203BBG73046MOST | National Natural Science Foundation of China (NSFC) 82203032, 32260193Project for high and talent of Science and Technology Innovation in Jiangxi jxsq2023301110Start-up fund from the First Affiliated Hospital of Nanchang University NoneTraining Plan for Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Youth Talent Project 20212BCJ23036
6 · The paper itself

Abstract

The widespread prevalence of

Indexed as

Helicobacter InfectionsHelicobacter pyloriVaccinesAdjuvants, ImmunologicAnimalsAntibodies, BacterialBacterial VaccinesCholera ToxinCytokinesHumansMicePlasmidsAdjuvants, ImmunologicAntibodies, BacterialBacterial VaccinesCholera ToxinCytokinesVaccinesadjuvantdelivery vectorHelicobacter pylorirecombinant OMVsvaccine

Identifiers

PMID37889003
PMCPMC10652931
OpenAlexW4387966431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.